Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Chemours (CC) Research & Development (2016 - 2025)

Chemours has reported Research & Development over the past 12 years, most recently at $27.0 million for Q4 2025.

  • Quarterly results put Research & Development at $27.0 million for Q4 2025, up 3.85% from a year ago — trailing twelve months through Dec 2025 was $108.0 million (down 0.92% YoY), and the annual figure for FY2025 was $108.0 million, down 0.92%.
  • Research & Development for Q4 2025 was $27.0 million at Chemours, up from $26.0 million in the prior quarter.
  • Over the last five years, Research & Development for CC hit a ceiling of $32.0 million in Q3 2022 and a floor of $24.0 million in Q1 2021.
  • Median Research & Development over the past 5 years was $27.0 million (2021), compared with a mean of $27.4 million.
  • Biggest five-year swings in Research & Development: surged 35.0% in 2021 and later dropped 13.33% in 2023.
  • Chemours' Research & Development stood at $29.0 million in 2021, then rose by 3.45% to $30.0 million in 2022, then dropped by 13.33% to $26.0 million in 2023, then changed by 0.0% to $26.0 million in 2024, then grew by 3.85% to $27.0 million in 2025.
  • The last three reported values for Research & Development were $27.0 million (Q4 2025), $26.0 million (Q3 2025), and $28.0 million (Q2 2025) per Business Quant data.